Nicotinic Acid Market

Nicotinic Acid Market Size and Share Forecast Outlook 2025 to 2035

The global nicotinic acid market is projected to grow from USD 362.4 million in 2025 to USD 601.7 million by 2035, registering a CAGR of 5.2%.

Quick Stats for Nicotinic Acid Market

• Market Value (2025): USD 362.4 million
• Forecast Value (2035): 601.7 million
• Forecast CAGR: 5.2%
• Source Leader in 2025: Synthetic (55% market share)
• Top Form Segment: Powder (45% share)
• Key Growth Region: East Asia (Japan is the fastest-growing market with a 4.9% CAGR)

Metric	Value
Industry Size (2025E)	USD 362.4 million
Industry Value (2035F)	USD 601.7 million
CAGR (2025 to 2035)	5.2%

This growth is driven by rising awareness of vitamin B3 (niacin) benefits in managing metabolic disorders, skin health, and nervous system regulation. Increased consumption of functional foods, fortified beverages, and dietary supplements featuring nicotinic acid and nicotinamide is accelerating market uptake. Additionally, the pharmaceutical industry's rising use of nicotinic derivatives in anti-inflammatory and cardiovascular applications contributes to the expanding demand.

The market holds an 8.4% share, largely through niacin-based supplements. In the pharmaceutical ingredients market, the share is around 3.2%, due to use in lipid-lowering formulations and skin therapies. Within the personal care ingredients market, the share remains modest at 1.5%, primarily in anti-aging creams. In the fortified food and beverage segment, nicotinic compounds contribute about 2.6%, especially in energy drinks, cereals, and protein bars.

Government and health regulations play a critical role in shaping the market. The USA FDA, EFSA, and FSSAI set fortification limits and health claim regulations for niacin in supplements and foods. In India, the Prevention of Food Adulteration Act and guidelines from ICMR ensure controlled usage in functional food products. These regulatory frameworks encourage safe and effective nicotinic usage in both pharmaceuticals and consumer health products, supporting long-term market growth.

Japan is projected to be the fastest-growing market, expected to expandat a CAGR of 4.9% from 2025 to 2035. Synthetic will lead the source segment with a 55% share, while powder will dominate the form segment with a 45% share. The USA and Germany are also expected to grow steadily at CAGRs of 4.8% and 4.5%, respectively.

Nicotinic Acid Market Analysis by Top Investment Segments

The market is segmented by form, grade, source, end-use industry, and region. By form, the market is divided into powder, liquid, and tablets/capsules. In terms of grade, the market is classified into feed grade, food grade, and pharmaceutical grade. Based on source, the market is bifurcated into natural and synthetic.

By the end-use industry, the market is segmented into dietary supplements, functional foods &beverages, infant food, animal feed, personal care, pharmaceuticals, and others (sports nutrition blends, veterinary health tonics, senior wellness formulas, and functional confectionery).

Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Powder to Lead the Form Segment with 45% Market Share in 2025

Powderis projected to hold the highest market share among all forms, accounting for 45% of global demand in 2025. This form is widely used in supplements, functional beverages, and pharmaceutical blends due to its compatibility, long shelf life, and ease of transportation. Its granular nature also makes it ideal for bulk packaging and efficient downstream formulation.

• Powder form allows convenient blending into capsules, tablets, and drink powders.
• Preferred for its high stability and lower storage cost in B2B production.
• Common across multivitamin formulations and clinical niacin supplements.

Pharmaceutical Grade to Capture the Grade Segment with 40% Market Share

Pharmaceuticalgrade is projected to leadthe grade segment in 2025, capturing a 40% market share globally. Its dominance stems from extensive use in treating hypercholesterolemia, niacin deficiency, and neurodegenerative disorders. High purity and regulatory compliance also favor this grade across prescription-based channels.

• Used in statin alternatives and blood lipid regulators.
• Meets pharmacopeial quality standards (USP, EP).
• Preferred by hospitals, clinics, and OTC pharma brands.

Synthetic to Lead the Source Segment with 55% Share in 2025

Synthetic is expected to dominate the source category, capturinga 55% global market share in 2025. The growth is driven by its cost efficiency, batch-to-batch consistency, and high scalability. Its purity and processing speed make it ideal for contract manufacturing and fortified food applications.

• Scalable production and regulatory clarity support synthetic dominance.
• Used heavily in food fortification and commercial supplements.
• Reliable sourcing ensures consistent supply to global brands.

Dietary Supplements to Dominate the End-use Industry with 38% Share in 2025

Dietary supplements are projected to remain the leading end-use industry, holding a 38% share of the global market in 2025. Rising awareness about vitamin B3’s role in energy metabolism, skin care, and heart health has made niacin a staple in both standalone supplements and complex multivitamin products.

• Strong growth in direct-to-consumer nutraceutical channels.
• Adopted in immunity blends, anti-aging formulations, and energy packs.
• Supported by health campaigns promoting preventive wellness.

Top Nicotinic Acid Market Dynamics

The global nicotinic acid market is experiencing steady growth, driven by increasing awareness around preventive health, skin nourishment, and energy metabolism. Nicotinic acid (niacin) plays a vital role in cardiovascular support and neurological health, making it a key ingredient across supplements, fortified foods, and pharmaceutical formulations. Expanding use in the beauty and personal care industry also adds to its demand.

Recent Trends in the Nicotinic Acid Market

• The integration of nicotinamide and niacinamide in cosmeceuticals is expanding rapidly due to their anti-aging, anti-inflammatory, and brightening properties.
• The rise of clean-label and plant-based nutraceuticals is encouraging innovation in naturally sourced nicotinic acid alternatives.
• Increasing adoption of sustained-release niacin formulations in pharma for better lipid control and reduced side effects is gaining popularity in clinical settings.

Challenges in the Nicotinic Acid Market

• Flushing and skin irritation associated with high-dose nicotinic acid supplements hinder acceptance in some consumer segments.
• Strict dosage regulation by bodies such as the FDA, EFSA, and FSSAI limit formulation flexibility, impacting product development timelines.
• Price volatility in raw materials, especially from fermentation-based production routes, creates cost unpredictability for smaller players.

Top Countries Manufacturing, Regulating, and Driving Demand for Nicotinic Acid

Japan’s momentum in the nicotinic acid market is driven by functional foods, clinical-grade skincare, and therapeutic vitamins. Germany and France maintain strong demand due to pharmaceutical-grade niacin usage and EU-backed wellness campaigns. The USA, UK, and Japan are growing at a steady 0.97-1.00x of the global CAGR of 4.9%.

The nicotinic acid market is expected to expandat most rapidly in Japan, growing at 4.9% CAGR from 2025 to 2035, followed by Germany (4.5%), France (4.4%), USA (4.8%), and UK (4.3%). Japan leads due to ultra-premium skincare formulations and advanced supplement formats. Western countries focus on regulated therapeutic dosing and preventive healthcare programs.

The report covers an in-depth analysis of 40+ countries; five top-performing OECD countries are highlighted below.

In-depth Analysis of Nicotinic Acid Demand in Japan

The Japan nicotinic acid market is projected to grow at a CAGR of 4.9% from 2025 to 2035.Growth is driven by innovations in dermaceuticals, nutricosmetics, and functional beverages. The popularity of niacinamide-based skin brightening serums and oral beauty supplements drives strong demand in urban centers.

• High demand in beauty drinks, anti-aging skincare, and OTC vitamins.
• Regulatory alignment supports clean-label and therapeutic-grade niacin.

Growth Outlook for Nicotinic Acid in Germany

The Germany nicotinic acid revenueis expected to expandat a CAGR of 4.5% during the forecast period.Pharmaceutical-grade nicotinic acid is widely used for cholesterol control and neuropathy. EU compliance for supplement labeling and purity enhances trust. Germany also sees rising use of niacinamide in organic-certified skincare and clean nutrition.

• Emphasis on lipid-lowering therapies and fortified multivitamins.
• Clean beauty trend strengthens demand in skincare sector.

Industrial Nicotinic Acid Demand in France

The Frenchnicotinic acid market is growing at a CAGR of 4.4% from 2025 to 2035.France focuses on wellness and clinical nutrition, with niacin supplementation increasingly common among seniors and women.

• Dermocosmetic R&D accelerating niacinamide integration.
• Preventive care fuels steady pharmaceutical demand.

Demand Trajectory for Nicotinic Acid in the USA

The demand for nicotinic acid in the USA is projected to grow at a CAGR of 4.8%.Clinical-grade extended-release niacin is widely used for hyperlipidemia, with demand supported by rising obesity and metabolic disorder rates.

• High use in cardiovascular support supplements.
• Fast adoption of plant-based niacin in clean-label health products.

Nicotinic Acid Trends in UK

The UK nicotinic acid revenueis forecast to grow at a CAGR of 4.3% between 2025 and 2035. Usage is centered on nutritional support, cosmetic formulations, and preventive healthcare. The National Health Service (NHS) supports nicotinic supplementation for pregnancy and postnatal care.

• Strong interest in women's health and dermatology.
• Pharmacy chains dominate supplement sales channel.

Leading Nicotinic Acid Suppliers and Manufacturers

The market is moderately consolidated, with key players including Lonza Group, BASF SE, Zhejiang NHU Co., Ltd., Vertellus Holdings LLC, and Brother Enterprises leading the supply chain. These companies focus on high-purity niacin (nicotinic acid) and niacinamide production for use in pharmaceuticals, personal care, and dietary supplements.

Lonza Group is known for pharmaceutical-grade nicotinic acid production, catering to clinical therapies. BASF SE offers a wide vitamin portfolio including niacinamide for food fortification and personal care. Zhejiang NHU Co., Ltd. and Brother Enterprises lead in large-scale industrial synthesis of niacin for fortified foods and feed additives. Vertellus specializes in customized niacinamide derivatives for cosmetics and functional beverages.

Recent Nicotinic Acid Industry News

• In May 2025, BASF SE finalized the acquisition of DOMO Chemicals’ 49% share in the Alsachimie joint venture, becoming the sole owner of the production entity for essential polyamide 6.6 precursors in Chalampé, France.
• In January 2025, Jubilant Ingrevia commissioned a new cGMP facility for Niacinamide production, featuring high bio-content to cater to global leaders in food, nutrition, and cosmetics.

Nicotinic Acid Market Report Scope

Report Attributes	Details
Market Size (2025)	USD 362.4 million
Projected Market Size (2035)	USD 601.7 million
CAGR (2025 to 2035)	5.2%
Base Year for Estimation	2024
Historical Period	2020 to 2024
Projections Period	2025 to 2035
Report Parameter	USD million for value/Volume in metric tons
Form Analyzed	Powder, Liquid, and Tablets/Capsules
Grade Analyzed	Feed Grade, Food Grade, and Pharmaceutical Grade
Source Analyzed	Natural and Synthetic
End-use Industry Analyzed	Dietary Supplements, Functional Foods & Beverages, Infant Food, Animal Feed, Personal Care, Pharmaceuticals, and Others (Sports Nutrition Blends, Veterinary Health Tonics, Senior Wellness Formulas, a nd Functional Confectioner y)
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, Middle East & Africa
Countries Covered	United States, United Kingdom, Germany, France, Japan, China, India, Brazil, South Korea, Australia
Key Players Influencing the Market	Graham Chemical, Glanbia plc, Lonza Group AG, Jubilant Life Sciences Ltd., NutraScience Labs, DSM, BASF SE, Western Drugs Ltd., Spectrum Chemical Mfg. Corp, Fengchen Group Co., Ltd
Additional Attributes	Dollar sales by form and grade, share by source, regional demand growth, regulatory influence, pharmaceutical adoption trends, competitive benchmarking

Key Segments

By Form:

As per form, the industry has been categorized into Powder, Liquid, and Tablets/Capsules.

By Grade:

This segment is further categorized into Feed Grade, Food Grade, and Pharmaceutical Grade.

By Source:

This segment is further categorized into Natural and Synthetic.

By End-use Industry:

This segment is further categorized into Dietary Supplements, Functional Foods and Beverages, Infant Food, Animal Feed, Personal Care, Pharmaceuticals, and Others.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Western Europe, Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.